Table 3.
Variable | Factor | HR (95% CI) | P-value |
---|---|---|---|
Overall survival | |||
H-grade | Low & intermediate vs. high | 18.148 (2.397−137.279) | 0.005 |
Disease-free survival | |||
T-stage | T1−2 vs. T3−4 | 3.628 (1.383−9.514) | 0.009 |
D-grade | G1−2 vs. G3 | 3.460 (1.373−8.722) | 0.009 |
Locoregional control | |||
T-stage | T1−2 vs. T3−4 | 8.189 (1.798−37.302) | 0.007 |
Distant control | |||
LVI | No vs. yes | 19.179 (1.513−243.153) | 0.023 |
HR, hazard ratio; CI, confidential interval; H, histologic; D, differentiation; LVI, lymphovascular invasion.